Aclaris Therapeutics
ACRS
ACRS
102 hedge funds and large institutions have $703M invested in Aclaris Therapeutics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 104 → 102 (-2)
13.9% less ownership
Funds ownership: 106.29% → 92.38% (-14%)
99% less call options, than puts
Call options by funds: $20K | Put options by funds: $1.49M
Holders
102
Holding in Top 10
3
Calls
$20K
Puts
$1.49M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$16.2M | |
| 3 | +$14M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.7M |
| 5 |
BlackRock
New York
|
+$12M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$29.9M | |
| 3 | -$17.7M | |
| 4 |
NC
Nexthera Capital
New York
|
-$10.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.78M |